Elacestrant Combos Can Open New Pathways in ESR1 Breast Cancer Treatment
According to Maxwell Lloyd, MD, a fellow in hematology-oncology at Beth Israel Deaconess Medical Center, elacestrant (Orserdu) has become a viable treatment for patients with ESR1-mtutated metastatic breast cancer, particularly in the later lines of …